BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19758223)

  • 1. Statins for the treatment of antiphospholipid syndrome?
    Jajoria P; Murthy V; Papalardo E; Romay-Penabad Z; Gleason C; Pierangeli SS
    Ann N Y Acad Sci; 2009 Sep; 1173():736-45. PubMed ID: 19758223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model.
    Ferrara DE; Liu X; Espinola RG; Meroni PL; Abukhalaf I; Harris EN; Pierangeli SS
    Arthritis Rheum; 2003 Nov; 48(11):3272-9. PubMed ID: 14613293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
    Erkan D; Willis R; Murthy VL; Basra G; Vega J; Ruiz-Limón P; Carrera AL; Papalardo E; Martínez-Martínez LA; González EB; Pierangeli SS
    Ann Rheum Dis; 2014 Jun; 73(6):1176-80. PubMed ID: 23933625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic endothelial cell markers in primary antiphospholipid syndrome.
    Williams FM; Parmar K; Hughes GR; Hunt BJ
    Thromb Haemost; 2000 Nov; 84(5):742-6. PubMed ID: 11127848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.
    López-Pedrera C; Ruiz-Limón P; Aguirre MÁ; Barbarroja N; Pérez-Sánchez C; Buendía P; Rodriguez-García IC; Rodriguez-Ariza A; Collantes-Estevez E; Velasco F; Khasmahta M; Cuadrado MJ
    Ann Rheum Dis; 2011 Apr; 70(4):675-82. PubMed ID: 21173016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab.
    Klimiuk PA; Sierakowski S; Domysławska I; Fiedorczyk M; Chwiećko J
    Arch Immunol Ther Exp (Warsz); 2004; 52(1):36-42. PubMed ID: 15053231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
    Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
    Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM
    Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
    Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M;
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
    Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
    J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal seizures after treatment with fluvastatin in a patient with a history of catastrophic antiphospholipid syndrome.
    Miesbach W; Chapman J; Scharrer I
    J Neurol Sci; 2005 Nov; 238(1-2):93-5. PubMed ID: 16111706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.
    Tekin A; Sezgin N; Katircibaşi MT; Tekin G; Cölkesen Y; Sezgin AT; Müderrisoğlu H
    Coron Artery Dis; 2008 Nov; 19(7):513-9. PubMed ID: 18923248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of circulating vascular endothelial growth factor and soluble adhesion molecules as reliable predictors of native arteriovenous fistula thrombosis in chronic hemodialysis patients.
    Zohny SF; Abd el-Fattah M
    Clin Biochem; 2008 Oct; 41(14-15):1175-80. PubMed ID: 18692491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.
    Ferrara DE; Swerlick R; Casper K; Meroni PL; Vega-Ostertag ME; Harris EN; Pierangeli SS
    J Thromb Haemost; 2004 Sep; 2(9):1558-63. PubMed ID: 15333031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin and fluvastatin reduce viremia and the pro-inflammatory cytokines in the patients with chronic hepatitis C.
    Mihăilă R; Nedelcu L; Frăţilă O; Rezi EC; Domnariu C; Ciucă R; Zaharie AV; Olteanu A; Bera L; Deac M; Mihăilă R
    Hepatogastroenterology; 2009; 56(96):1704-9. PubMed ID: 20214221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; de Larrañaga GF
    Lupus; 2005; 14(2):129-36. PubMed ID: 15751817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
    Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
    Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin attenuates severe hemorrhagic shock-induced organ damage in rats.
    Lee CC; Lee RP; Subeq YM; Lee CJ; Chen TM; Hsu BG
    Resuscitation; 2009 Mar; 80(3):372-8. PubMed ID: 19150166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.